Literature DB >> 10098745

Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.

Y Doki1, K Murakami, T Yamaura, S Sugiyama, T Misaki, I Saiki.   

Abstract

This study is designed to establish a pulmonary tumour model to investigate the biology and therapy of lung cancer in mice. Current methods for forming a solitary intrapulmonary nodule and subsequent metastasis to mediastinal lymph nodes are not well defined. Lewis lung carcinoma (LLC) cell suspensions were orthotopically introduced into the lung parenchyma of C57/BL6 mice via a limited skin incision without thoracotomy followed by direct puncture through the intercostal space. The implantation process was performed within approximately 50 s per mouse, and the operative mortality was less than 5%. Single pulmonary nodules developed at the implanted site in 93% of animals and subsequent mediastinal lymph node metastasis was observed in all mice that formed a lung nodule after intrapulmonary implantation. The size of tumour nodule and the weight of mediastinal lymph node increased in a time-dependent manner. The mean survival time of mice implanted successfully with LLC cells was 21+/-2 days (range 19-24 days). Histopathological analysis revealed that no metastatic tumour was detectable in the mediastinal lymph nodes on day 11, but metastatic foci at mediastinal lymph nodes were clearly observed on days 17 and 21 after implantation. Other metastases in distant organs or lymph nodes were not observed at 21 days after the implantation. Comparative studies with intrapleural and intravenous injections of LLC cells suggest that the mediastinal lymph node metastasis by intrapulmonary implantation is due to the release of tumour cells from the primary nodule, and not due to extrapulmonary leakage of cells. An intravenous administration of cis-diamine dichloro platinum on day 1 after tumour implantation tended to suppress the primary tumour nodule and significantly inhibited lymph node metastasis. Thus, a solitary pulmonary tumour nodule model with lymph node metastasis approximates clinical lung cancer and may provide a useful basis for lung cancer research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098745      PMCID: PMC2362254          DOI: 10.1038/sj.bjc.6690178

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Comparison of intrapulmonary, percutaneous intrathoracic, and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice.

Authors:  T L McLemore; J C Eggleston; R H Shoemaker; B J Abbott; M E Bohlman; M C Liu; D L Fine; J G Mayo; M R Boyd
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

2.  A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice.

Authors:  X Wang; X Fu; R M Hoffman
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

3.  Irradiated nude rat model for orthotopic human lung cancers.

Authors:  R B Howard; H Chu; B E Zeligman; T Marcell; P A Bunn; T L McLemore; D W Mulvin; M E Cowen; M R Johnston
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

4.  Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice.

Authors:  K Morikawa; S M Walker; M Nakajima; S Pathak; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

5.  Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.

Authors:  R Fridman; G Giaccone; T Kanemoto; G R Martin; A F Gazdar; J L Mulshine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer.

Authors:  R Nakanishi; T Osaki; K Nakanishi; I Yoshino; T Yoshimatsu; H Watanabe; H Nakata; K Yasumoto
Journal:  Ann Thorac Surg       Date:  1997-08       Impact factor: 4.330

7.  Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.

Authors:  T L McLemore; M C Liu; P C Blacker; M Gregg; M C Alley; B J Abbott; R H Shoemaker; M E Bohlman; C C Litterst; W C Hubbard
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

8.  Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel.

Authors:  R Fridman; M C Kibbey; L S Royce; M Zain; M Sweeney; D L Jicha; J R Yannelli; G R Martin; H K Kleinman
Journal:  J Natl Cancer Inst       Date:  1991-06-05       Impact factor: 13.506

9.  Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.

Authors:  S Naito; A C von Eschenbach; R Giavazzi; I J Fidler
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

10.  Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.

Authors:  J E Talmadge; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

View more
  36 in total

1.  Recent developments in morphology of lymphatic vessels and lymph nodes.

Authors:  Osamu Ohtani; Yuko Ohtani
Journal:  Ann Vasc Dis       Date:  2012

2.  An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.

Authors:  Xiwu Chen; Yan Su; Barbara Fingleton; Heath Acuff; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model.

Authors:  B Rashidi; M Yang; P Jiang; E Baranov; Z An; X Wang; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer.

Authors:  K Ichiki; N Mitani; Y Doki; H Hara; T Misaki; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.

Authors:  Wei Yu; Li Chen; Yu-Qing Yang; John R Falck; Austin M Guo; Ying Li; Jing Yang
Journal:  Cancer Chemother Pharmacol       Date:  2010-12-01       Impact factor: 3.333

6.  A novel bioluminescence orthotopic mouse model for advanced lung cancer.

Authors:  Bo Li; Artour Torossian; Wenyan Li; Stephen Schleicher; Kathy Niu; Nicholas J Giacalone; Sung June Kim; Heidi Chen; Adriana Gonzalez; Luigi Moretti; Bo Lu
Journal:  Radiat Res       Date:  2011-06-10       Impact factor: 2.841

7.  Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel.

Authors:  Florian Hohla; Andrew V Schally; Karoly Szepeshazi; Jozsef L Varga; Stefan Buchholz; Frank Köster; Elmar Heinrich; Gabor Halmos; Ferenc G Rick; Chandrika Kannadka; Christian Datz; Celia A Kanashiro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

8.  Contrast agents for quantitative microCT of lung tumors in mice.

Authors:  Kush Lalwani; Anand Giddabasappa; Danan Li; Peter Olson; Brett Simmons; Farbod Shojaei; Todd Van Arsdale; James Christensen; Amy Jackson-Fisher; Anthony Wong; Patrick B Lappin; Jeetendra Eswaraka
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

9.  WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Authors:  Don X Nguyen; Anne C Chiang; Xiang H-F Zhang; Juliet Y Kim; Mark G Kris; Marc Ladanyi; William L Gerald; Joan Massagué
Journal:  Cell       Date:  2009-07-02       Impact factor: 41.582

10.  Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.

Authors:  Florian Hohla; Andrew V Schally; Celia A Kanashiro; Stefan Buchholz; Benjamin Baker; Chandrika Kannadka; Angelika Moder; Elmar Aigner; Christian Datz; Gabor Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.